Daily Pill Could Revolutionise Cancer Treatment
The title of this post, is the same as that of this article in the Sunday Times.
This is the sub-heading.
Doctors hail the ‘holy grail’ of research that provides hope to patients and families facing the disease.
These three paragraphs introduce the article.
A daily pill that doubles life expectancy for pancreatic cancer sufferers may revolutionise treatment for millions of people, experts believe.
Researchers found the drug significantly extended the lives of patients by targeting a specific mutation.
The pill, daraxonrasib, is the biggest breakthrough in decades for pancreatic cancer, which is notoriously difficult to treat.
No comments yet.
Leave a comment